Knowledge is power in driving pharma commercialization success
Two Labs is an industry leader in all facets of pharma services. Our professional, experienced team offers a wealth of skills and knowledge to manage the complexities of pharma product commercialization, market access and market intelligence.
In February of this year, CEEK Enterprises brought to the Two Labs Family a new echelon of specialized expertise in life sciences corporate development, commercial strategy, clinical development and medical affairs.
The noisy workshop inside the Hilltop nonprofit Run the Race Center was filled with buzzing saws cutting into wood and whizzing drills connecting the pieces together.
The cost of treating cancer patients is high and rising in the United States. Payers are exposed to cost through doctor visits, laboratory tests, imaging tests, radiation treatment, drugs, hospital stays, surgery, home care, transportation and travel, and caregiving.
With the recent patent expiry of Humira® (adalimumab) in Europe, NHS England last week published a press release reiterating their goal of realizing £300 million in annual savings through the adoption of best value biologic medicines (originator or biosimilar) by 2021.
Industry-leading pharmaceutical services company, Two Labs, today announced it has acquired Pennside Partners Ltd., an international provider of market insights, benchmarking and competitive intelligence services for the pharmaceutical, biotech, and medical device sectors.
